Pulmonary hypertension in interstitial lung disease

Area of Science:

• Pulmonology
• Cardiology
• Internal Medicine

Background:

• Pulmonary hypertension (PH) is a serious complication in advanced interstitial lung disease (ILD).
• PH significantly worsens prognosis for patients with ILD.
• The underlying causes of PH in ILD are multifactorial and vary across different ILD subtypes.

Purpose of the Study:

• To explore the complex relationship between pulmonary hypertension and interstitial lung disease.
• To identify the common ILD conditions associated with PH.
• To investigate the potential for therapeutic modification of PH in ILD.

Main Methods:

• Literature review of studies investigating PH in ILD.
• Analysis of etiological factors contributing to PH in various ILD types.
• Identification of common ILD conditions associated with PH, including idiopathic pulmonary fibrosis, sarcoidosis, connective tissue disease-related ILD, and pulmonary Langerhans cell histiocytosis.

Main Results:

• Pulmonary hypertension frequently complicates advanced interstitial lung disease.
• Common ILD types associated with PH include idiopathic pulmonary fibrosis, sarcoidosis, CTD-ILD, and PLCH.
• The etiology of PH in ILD is multifactorial, with varying contributions from different factors.

Conclusions:

• PH is a significant negative prognostic factor in advanced ILD.
• Understanding the multifactorial etiology of PH in ILD is crucial.
• Further research is needed to determine if therapeutic interventions can alter the course and impact of PH in these conditions.